Ortho-McNeil Pharmaceutical, Inc.
369Patents
44Active
369Granted
43Portfolio score
Filing activity: Sep 24, 1992 → Jul 17, 2012 · 41 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6372246B1 | Polyethylene glycol coating for electrostatic dry deposition of pharmaceuticals | Human Necessities | 151 | Expired |
| US6627246B2 | Process for coating stents and other medical devices using super-critical carbon dioxide | Human Necessities | 94 | Expired |
| US6149935A | Solid matrix system for transdermal drug delivery | Human Necessities | 86 | Expired |
| US6323219A | Methods for treating immunomediated inflammatory disorders | Human Necessities | 65 | Expired |
| US6686337B2 | Combination therapy comprising anti-diabetic and anticonvulsant agents | Human Necessities | 65 | Expired |
| US6509369B2 | Anti-inflammatory compounds | Chemistry; Metallurgy | 60 | Expired |
| US7867990B2 | Steroid hormone products and methods for preparing them | Human Necessities | 59 | Expired |
| US7354742B2 | Method for generating amplified RNA | Chemistry; Metallurgy | 56 | Expired |
| US6696056B1 | Pharmaceutical compositions of erythropoietin | Human Necessities | 55 | Expired |
| US6162456A | Adhesive transdermal drug delivery matrix of a physical blend of hydrophilic and hydrophobic polymers | Emerging Cross-Sectional Technologies | 54 | Expired |
| US6140354A | N-substituted aminotetralins as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders | Chemistry; Metallurgy | 53 | Expired |
| US7074779B2 | Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors | Human Necessities | 52 | Expired |
| US6077939A | Methods and kits for making polypeptides having a single covalently bound N-terminal water-soluble polymer | Chemistry; Metallurgy | 45 | Expired |
| US6319903A | Anticonvulsant derivatives useful in treating cluster headaches | Human Necessities | 44 | Expired |
| US6653478B2 | Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide Y modulators | Chemistry; Metallurgy | 42 | Expired |
| USRE39221E1 | Composition comprising a tramadol material and acetaminophen and its use | General | 39 | Expired |
| US6562865B1 | Composition comprising a tramadol material and an anticonvulsant drug | Human Necessities | 39 | Expired |
| US6747002B2 | Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration | Human Necessities | 38 | Expired |
| US6201010A | Anticonvulsant derivatives useful in lowering blood pressure | Human Necessities | 38 | Expired |
| US6399582B1 | Ketolide antibacterials | Human Necessities | 38 | Expired |
| US6310078A | Substituted amino acids as erythropoietin mimetics | Chemistry; Metallurgy | 38 | Expired |
| US6806256B2 | Taste masked liquid pharmaceutical compositions | Human Necessities | 38 | Expired |
| US5935933A | Anticonvulsant derivatives useful in treating neuropathic pain | Human Necessities | 37 | Expired |
| US6071531A | Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen | Human Necessities | 36 | Expired |
| US6818613B2 | Aqueous sustained-release formulations of proteins | Human Necessities | 36 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.